Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.
Diabetologia. 2024 Apr;67(4):690-702. doi: 10.1007/s00125-023-06082-4. Epub 2024 Jan 11.
Diabetologia. 2024.
PMID: 38206363
Free PMC article.
The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study.
Werkman NCC, Driessen JHM, Stehouwer CDA, Vestergaard P, Schaper NC, van den Bergh JP, Nielen JTH.
Werkman NCC, et al.
Cardiovasc Diabetol. 2023 Jun 29;22(1):160. doi: 10.1186/s12933-023-01897-2.
Cardiovasc Diabetol. 2023.
PMID: 37386427
Free PMC article.
Item in Clipboard
Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study.
van Dalem J, Werkman NCC, van den Bergh JP, Rossi B, Viggers R, Eastell R, Burden AM, Stehouwer CDA, Klungel OH, Brouwers MCGJ, Driessen JHM.
van Dalem J, et al. Among authors: werkman ncc.
Diabetes Res Clin Pract. 2022 Aug;190:109993. doi: 10.1016/j.diabres.2022.109993. Epub 2022 Jul 14.
Diabetes Res Clin Pract. 2022.
PMID: 35842030
Free article.
Item in Clipboard
Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer.
Røikjer J, Werkman NCC, Ejskjaer N, van den Bergh JPW, Vestergaard P, Schaper NC, Jensen MH, Klungel O, de Vries F, Nielen JTH, Driessen JHM.
Røikjer J, et al. Among authors: werkman ncc.
Diabet Med. 2022 Apr;39(4):e14725. doi: 10.1111/dme.14725. Epub 2021 Oct 22.
Diabet Med. 2022.
PMID: 34657300
Item in Clipboard
Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb Amputation.
Werkman NCC, Nielen JTH, van den Bergh JPW, Ejskjaer N, Røikjer J, Schaper NC, Rossi B, Klungel O, Vestergaard P, de Vries F, Driessen JHM.
Werkman NCC, et al.
Curr Drug Saf. 2021;16(1):62-72. doi: 10.2174/1574886315666200805103053.
Curr Drug Saf. 2021.
PMID: 32767909
Item in Clipboard
Cite
Cite